Smith & Nephew SNATS Inc Market Cap ($12.78 Billion)
Market Cap & Net Worth: Smith & Nephew SNATS Inc (SNN)
Smith & Nephew SNATS Inc market cap. Smith & Nephew SNATS Inc (NYSE:SNN) has a market capitalization of $12.78 Billion ($12.78 Billion) as of November 7, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1803 globally and #686 in its home market, demonstrating a 6.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Smith & Nephew SNATS Inc's stock price $32.01 by its total outstanding shares 426824573 (426.82 Million). Also see how efficiently does Smith & Nephew SNATS Inc generate cash for how efficiently the company converts equity into cash flow.
Smith & Nephew SNATS Inc Market Cap History (2015–2026)
Smith & Nephew SNATS Inc market cap history from 2015 to 2026. Data shows growth from $12.44 Billion to $13.66 Billion (0.81% CAGR). Check SNN stock price for real-time trading data and today's change.
Smith & Nephew SNATS Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Smith & Nephew SNATS Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SNN year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.27x
Smith & Nephew SNATS Inc's market cap is 2.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
22.35x
Smith & Nephew SNATS Inc's market cap is 22.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $10.70 Billion | $4.67 Billion | $784.00 Million | 2.29x | 13.65x |
| 2017 | $12.69 Billion | $4.76 Billion | $767.00 Million | 2.66x | 16.55x |
| 2018 | $13.82 Billion | $4.90 Billion | $663.00 Million | 2.82x | 20.85x |
| 2019 | $18.08 Billion | $5.14 Billion | $600.00 Million | 3.52x | 30.14x |
| 2020 | $16.20 Billion | $4.56 Billion | $448.00 Million | 3.55x | 36.17x |
| 2021 | $13.58 Billion | $5.21 Billion | $524.00 Million | 2.60x | 25.91x |
| 2022 | $10.83 Billion | $5.21 Billion | $223.00 Million | 2.08x | 48.59x |
| 2023 | $11.32 Billion | $5.55 Billion | $263.00 Million | 2.04x | 43.02x |
| 2024 | $10.49 Billion | $5.81 Billion | $412.00 Million | 1.81x | 25.46x |
| 2025 | $14.00 Billion | $6.18 Billion | $626.46 Million | 2.27x | 22.35x |
Competitor Companies of SNN by Market Capitalization
Companies near Smith & Nephew SNATS Inc in the global market cap rankings as of November 7, 2026. Also see Smith & Nephew SNATS Inc total assets for a full breakdown of the balance sheet.
Key companies related to Smith & Nephew SNATS Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #106 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #181 globally with a market cap of $128.53 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #106 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $113.60 |
| #181 | Stryker Corporation | NYSE:SYK | $128.53 Billion | $335.08 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.84 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Smith & Nephew SNATS Inc (2015–2026)
Market capitalization of Smith & Nephew SNATS Inc from 2015 to today. Between 2015 and today, Smith & Nephew SNATS Inc's market cap moved from $12.44 Billion to $ 13.66 Billion, with a yearly change of 0.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.66 Billion | -2.44% |
| 2025 | $14.00 Billion | +33.48% |
| 2024 | $10.49 Billion | -7.28% |
| 2023 | $11.32 Billion | +4.44% |
| 2022 | $10.83 Billion | -20.20% |
| 2021 | $13.58 Billion | -16.21% |
| 2020 | $16.20 Billion | -10.40% |
| 2019 | $18.08 Billion | +30.84% |
| 2018 | $13.82 Billion | +8.90% |
| 2017 | $12.69 Billion | +18.57% |
| 2016 | $10.70 Billion | -13.93% |
| 2015 | $12.44 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Smith & Nephew SNATS Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.78 Billion USD |
| MoneyControl | $12.78 Billion USD |
| MarketWatch | $12.78 Billion USD |
| marketcap.company | $12.78 Billion USD |
| Reuters | $12.78 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Smith & Nephew SNATS Inc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more